MY152490A - New oral formulation - Google Patents
New oral formulationInfo
- Publication number
- MY152490A MY152490A MYPI0304586A MY152490A MY 152490 A MY152490 A MY 152490A MY PI0304586 A MYPI0304586 A MY PI0304586A MY 152490 A MY152490 A MY 152490A
- Authority
- MY
- Malaysia
- Prior art keywords
- oral formulation
- new oral
- composition
- new
- administering
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
THE PRESENT INVENTION RELATES TO A PHARMACEUTICAL COMPOSITION, IN PARTICULAR TO A COMPOSITION FOR ADMINISTERING OF ACTIVE AGENTS WHICH ARE POORLY SOLUBLE IN AQUEOUS MEDIA, AND/OR WHICH ARE ACID SENSITIVE.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9818340.3A GB9818340D0 (en) | 1998-08-21 | 1998-08-21 | Organic compounds |
| GBGB9910320.2A GB9910320D0 (en) | 1999-05-05 | 1999-05-05 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY152490A true MY152490A (en) | 2014-10-15 |
Family
ID=37001080
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI0304586 MY152490A (en) | 1998-08-21 | 1999-08-18 | New oral formulation |
| MYPI9903543 MY128958A (en) | 1998-08-21 | 1999-08-18 | New oral formulation for 5-ht4 agonists or antagonists. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI9903543 MY128958A (en) | 1998-08-21 | 1999-08-18 | New oral formulation for 5-ht4 agonists or antagonists. |
Country Status (5)
| Country | Link |
|---|---|
| AR (2) | AR018465A1 (en) |
| CO (1) | CO5130010A1 (en) |
| MY (2) | MY152490A (en) |
| PE (1) | PE20000865A1 (en) |
| TW (1) | TWI238725B (en) |
-
1999
- 1999-08-18 TW TW88114109A patent/TWI238725B/en not_active IP Right Cessation
- 1999-08-18 CO CO99052292A patent/CO5130010A1/en unknown
- 1999-08-18 MY MYPI0304586 patent/MY152490A/en unknown
- 1999-08-18 MY MYPI9903543 patent/MY128958A/en unknown
- 1999-08-18 PE PE1999000837A patent/PE20000865A1/en not_active IP Right Cessation
- 1999-08-19 AR ARP990104165 patent/AR018465A1/en active IP Right Grant
-
2001
- 2001-08-10 AR ARP010103838A patent/AR030340A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20000865A1 (en) | 2000-09-07 |
| MY128958A (en) | 2007-03-30 |
| AR030340A2 (en) | 2003-08-20 |
| CO5130010A1 (en) | 2002-02-27 |
| AR018465A1 (en) | 2001-11-14 |
| TWI238725B (en) | 2005-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU8701A (en) | New oral formulation | |
| HUP0302086A2 (en) | Oral pharmaceutical composition with a delayed action and process for its preparation | |
| WO2001090091A8 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| PL337794A1 (en) | Pharmaceutic agent for oral administration containing an active substance and cyclodextrin | |
| WO2000045800A3 (en) | Immunosurpressive effects of pteridine derivatives | |
| HK1045937A1 (en) | Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof | |
| HUP0202744A2 (en) | Oral controlled release formulations containing rivastigmine | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| AU5072000A (en) | Pharmaceutical composition for nasally administering water-soluble active substances | |
| HUP0200729A3 (en) | Hydroxamic acid derivatives, their use and preparation and pharmaceutical compositions containing them | |
| MY152490A (en) | New oral formulation | |
| TR200003451T2 (en) | Pyrimidine-Aminomethyl-Pyridine Derivatives, Their Preparation and Their Use in the Control of Helicobacter Bacteria | |
| HUP0200605A2 (en) | Hydroxamic acid derivatives, their preparation and use and pharmaceutical compositions containing them | |
| ECSP993104A (en) | NEW ORAL FORMULATION | |
| CR6300A (en) | NEW ORAL FORMULATION | |
| WO2001091733A3 (en) | Combination of active substances containing montirelin and a compound having an opioid effect | |
| YU87302A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |